by Clinical Neuropsychologist Online | Wednesday, April 3, 2024 | Dementia
Dementia, Volume 23, Issue 4, Page 525-549, May 2024. BackgroundDementia disproportionately affects women including persons living with dementia and caregivers. Person-centered care, rather than disease-focused, is recommended to improve care for affected persons...
by Clinical Neuropsychologist Online | Wednesday, April 3, 2024 | Dementia
Abstract INTRODUCTION Aducanumab selectively targets aggregated forms of amyloid beta (Aβ), a neuropathological hallmark of Alzheimer’s disease (AD). METHODS PRIME was a Phase 1b, double-blind, randomized clinical trial of aducanumab. During the 12-month...
by Clinical Neuropsychologist Online | Wednesday, April 3, 2024 | Paediatric Neuropsychology
Volume 13, Issue 3, July-September 2024, Page 269-281. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: Cathy Marlair Aude Guillon Menik Vynckier Virginie...
by Clinical Neuropsychologist Online | Wednesday, April 3, 2024 | Neuroscience
Nature Neuroscience, Published online: 03 April 2024; doi:10.1038/s41593-024-01612-8How astrocytes can integrate information is incompletely understood. Here the authors show that locus coeruleus-controlled calcium signals in hippocampal astrocytes propagating from...
by Clinical Neuropsychologist Online | Tuesday, April 2, 2024 | Dementia
Abstract INTRODUCTION Genome-wide association studies have identified numerous disease susceptibility loci (DSLs) for Alzheimer’s disease (AD). However, only a limited number of studies have investigated the dependence of the genetic effect size of established...
